Posted On: January 7, 2008 by Michael G. Donahue, III

Distribution of 40mg Methadone Tablets Restricted

The DEA and pharmaceutical manufacturers have reach agreement that action must be taken to reduce the increase in methadone related deaths.

As of January 1, 2008, manufacturers of methadone have agreed to restrict distribution of 40 mg tablets. Methadone was previously available in 5 mg, 10 mg and 40 mg tablet formulations. The 40 mg formulation is not FDA approved for use in pain management. Under an agreement reached with the DEA, 40 mg tablets will only be available to facilities authorized for detoxification or maintenance treatment of opiod addiction. Methadone manufacturers have instructed their distributors to discontinue supplying these tablets to other facilities such as pharmacies.